(YOLO) ADVISORSHARES PURE CANNABIS ETF
Cannabis and its various applications have been used throughout human civilization for over 5,000 years. As society, business and regulatory landscapes evolve in the 21st century, the upside potential of cannabis as an emerging investment avenue has arrived. The portfolio manager believes today’s new era can be viewed in similar regard to post-Prohibition, commencing a growing acknowledgement and understanding of cannabis and its uses among a mainstream audience. The industries that comprise the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities.
The AdvisorShares Pure Cannabis ETF (Ticker: YOLO) became the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. The AdvisorShares Pure Cannabis ETF, or YOLO, seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. YOLO is designed to fully-invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace.
|Symbol||Exchange||Inception Date||CUSIP||Indicative Value||Options|
<strong>Why Invest in YOLO?</strong>
- Long-Term Upside Potential – The emergence of select cannabis securities and their long-term growth potential adds a compelling element for investors seeking pure cannabis exposure and a potential high-growth complement to a broad-based equity allocation.
- First Active ETF with Dedicated Cannabis Exposure – YOLO became the first actively managed ETF with dedicated cannabis exposure available in the U.S., which carries inherent advantages. YOLO can adjust its portfolio more quickly than a passive index-based strategy – an important attribute in a rapidly evolving cannabis marketplace that can witness fluctuations and changes among tradeable equities and an influx of new stock issues.
- Experienced Portfolio Management Team – YOLO’s portfolio management team carries deep experience in the capital markets and a well-established expertise of investing in highly-regulated areas in the equity markets including cannabis. Their risk management and selective approach is an essential feature of YOLO, which does not blindly invest by following a market-cap-weighted index like other cannabis-related ETF offerings.
<strong>Where Can YOLO Fit in a Traditional Portfolio?</strong>
YOLO can deliver an alpha-seeking, high-growth complement or satellite equity holding to a broad-based equity allocation. YOLO can be used as a buy-and-hold strategy for investors seeking dedicated cannabis exposure for an equity portfolio.
- Dedicated Cannabis Exposure Including Consumer Product Companies – The portfolio manager allocates across a universe of investable cannabis companies primarily in the U.S. and Canada engaging in legal business that span different industries, including those specializing in consumer products.
- Emerging Growth Opportunity – Cannabis securities span multiple industries including agriculture, biotechnology, pharmaceutical, real estate, retail, finance, and other medical applications. The portfolio manager believes that an evolving landscape of select, cannabis-related companies may provide upside potential that may lead to attractive growth opportunities.
- Merger & Acquisition Potential – Due to their emerging growth opportunity, companies involved in legal cannabis-related business both in the U.S. and Canada may benefit from potential merger and acquisition activity as the market matures and evolves.
<strong>About the Portfolio Managers</strong>
Dan Ahrens is managing director and chief operating officer of AdvisorShares, and also portfolio manager of the AdvisorShares Vice ETF (Ticker: ACT). Dan carries over two decades of experience in the financial services industry serving in a variety of senior-level capacities. He founded Ahrens Advisors, L.P., an SEC-registered investment advisor, where he was portfolio manager of the Ladenburg Thalmann Gaming and Casino Fund. Dan also served as president of the MUTUALS.com Funds, where he launched the Vice Fund (VICEX) and served as its original portfolio manager. He was also the portfolio manager of the Generation Wave Growth Fund (GWGFX). During that time, he was also president and chief compliance officer of Mutuals Advisors, Inc, and acted as president, treasurer and financial & operations officer of an affiliated broker dealer firm. Dan is the author of “Investing in Vice” (St. Martin’s Press, 2004) and has appeared prominently across financial media outlets and major national and trade publications. He earned a Bachelor in Business Administration in Finance from Texas Tech University.
Robert M. Parker, CFA
Rob Parker is the director of capital markets for AdvisorShares, where he oversees trading, portfolio management and fund operations activity for the firm. He serves as portfolio manager for a number of funds including the AdvisorShares Vice ETF (Ticker: ACT). Rob’s professional career has spanned over a decade and a half within the financial services industry, where he has worked across compliance, due diligence, and investment analysis as well as positions of senior portfolio manager and firm principal. Rob managed assets for a proprietary investment practice that he created after serving as senior portfolio manager at ProShares Advisors, where he managed leveraged, inverse, and long-short ETFs. Rob previously held positions held at Capital Financial Group, Wachovia Securities, The Advisors Group, and FOLIOfn, serving in a variety of analyst roles. He is a graduate of National University, earning a Bachelor of Science. He holds the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society of Washington, DC
As of 5/27/2020
|4PM Bid/Offer Midpoint||$10.99||Premium Discount||$0.02|
|Assets Under Management||$45,522,297.11|
Shares are bought and sold at market price (closing price) not NAV and are not individually redeemed from the Fund. Market price returns are based on the midpoint of the bid/ask spread at 4:00 pm Eastern Time (when NAV is normally determined), and do not represent the return you would receive if you traded at other times.
As of 4/30/2020
|NAV||Market Price Return||S&P 500|
|Since Inception (04/17/2019, Cumulative)||-63.24||-63.38||0.00|
As of 3/31/2020
|NAV||Market Price Return||S&P 500|
|Since Inception (04/17/2019, Cumulative)||-67.08||-67.19||-9.18|
Performance data quoted represents past performance and is no guarantee of future results. All Fund data and performance data quoted is believed to be accurate, and unless otherwise stated, is sourced from the Fund administrator, the Advisor’s or Sub-Advisor’s proprietary data, and Morningstar. Current performance may be lower or higher than the performance data quoted. Investment return and principal value will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than original cost. Returns less than one year are not annualized.
As of 5/27/2020
|Date||Account Symbol||Stock Ticker||CUSIP/Number||Security||Shares||Price||Market Value||Weight %||Asset Group|
|05/27/2020||YOLO||VFF||92707Y108||VILLAGE FARMS INTERNATIONAL||745,560.00||5.59||4,167,680.40||9.19%||FS||1|
|IIPR||45781V101||INNOVATIVE INDUSTRIAL PROPER||48,420.00||84.25||4,079,385.00||8.99%||S||1|
|GWPH||36197T103||GW PHARMACEUTICALS -ADR||27,582.00||126.49||3,488,847.18||7.69%||FS||1|
|GTBIF||GTBIFTRS||GREEN THUMB INDUSTRIES SWAP REC||261,200.00||9.84||2,570,208.00||5.67%||TW||1|
|TCNNF||TCNNFTRS||TRULIEVE CANNABIS SWAP REC||180,800.00||13.16||2,380,033.12||5.25%||TW||1|
|ARNA||040047607||ARENA PHARMACEUTICALS INC||37,921.00||58.14||2,204,726.94||4.86%||S||1|
|CURLF||CURLFTRS||CURALEAF HOLDINGS INC SWAP REC||360,600.00||6.07||2,188,842.00||4.82%||TW||1|
|ZYNE||98986X109||ZYNERBA PHARMACEUTICALS INC||352,968.00||5.59||1,973,091.12||4.35%||S||1|
|VLNS||BD9FYC6||VALENS GROWORKS CORP||978,596.00||1.87||1,826,901.36||4.03%||FS||1|
|CGC||138035100||CANOPY GROWTH CORP||91,251.00||19.90||1,815,894.90||4.00%||FS|
|OGI||BQ963P6||ORGANIGRAM HOLDINGS INC||1,028,675.00||1.68||1,726,863.97||3.81%||FS|
|CRBP||21833P103||CORBUS PHARMACEUTICALS HOLDI||175,989.00||7.69||1,353,355.41||2.98%||S|
|NEPT||64079L105||NEPTUNE WELLNESS SOLUTIONS I||395,607.00||3.09||1,222,425.63||2.69%||FS|
|ALEF||BDRXWQ2||ALEAFIA HEALTH INC||2,432,503.00||0.44||1,073,680.77||2.37%||FS|
|RIV||BF5HVC9||CANOPY RIVERS INC||1,019,930.00||1.02||1,040,594.28||2.29%||FS|
|GNLN||395330103||GREENLANE HOLDINGS INC - A||267,641.00||3.67||982,242.47||2.17%||S|
|CWEB||BGHY2B1||CHARLOTTES WEB HOLDINGS INC||157,088.00||6.23||978,674.15||2.16%||FS|
|LABS||BG87WT7||MEDIPHARM LABS CORP||433,674.00||1.37||596,223.30||1.31%||FS|
|CRLBF||CRLBFTRS||CRESCO LABS INC SWAP REC||106,823.00||5.10||544,797.30||1.20%||TW|
|CRDL||BHZT969||CARDIOL THERAPEUTICS INC-A||225,770.00||2.05||462,322.07||1.02%||FS|
|KHRN||BDGH0L6||KHIRON LIFE SCIENCES CORP||503,765.00||0.58||291,615.05||0.64%||FS|
|EMH||BYQ0XN5||EMERALD HEALTH THERAPEUTICS||1,256,559.00||0.17||218,215.75||0.48%||FS|
|FIRE||BFN2HL7||SUPREME CANNABIS CO INC/THE||762,112.00||0.25||193,009.55||0.43%||FS|
|ITHUF||ITHUFTRS||IANTHUS CAPITAL HOLDINGS SWAP REC||464,000.00||0.40||184,208.00||0.41%||TW|
|TGOD||BG0DCR1||GREEN ORGANIC DUTCHMAN HOLDI||517,961.00||0.35||181,773.58||0.40%||FS|
|ACB||05156X884||AURORA CANNABIS INC||10,998.00||15.30||168,269.40||0.37%||FS|
|TLRY||88688T100||TILRAY INC-CLASS 2 COMMON||11,461.00||10.65||122,059.65||0.27%||S|
|NTEC||M53644106||INTEC PHARMA LTD||419,353.00||0.27||113,644.66||0.25%||FS|
|X9USDBLYT||BLACKROCK TREASURY TRUST INSTL 62||1,871,131.24||1.00||1,871,131.24||4.12%||MM|
Holdings and allocations are subject to risks and to change. A holding identified with an “MM” at the end of its name indicates it is a Money Market fund.
As of 2/29/2020
YOLO Market Cap
YOLO Regional Allocation
As of 4/30/2020
|30-Day SEC Subsidized Yield||4.13%||0.00|
|30-Day SEC Unsubsidized Yield||3.24%||0.00|
Past Performance is not indicative of future results. 30–Day SEC Yield (Standardized Yield) is an annualized yield that is calculated by dividing the investment income earned by the Fund less expenses over the most recent 30-day period by the current maximum offering price. Securities lending and swap income are included as part of the yield calculation, provided by BNY.
Fees & Expenses
|Gross Expense Ratio||1.10%|
|Fee Waiver and/or Expense Reimbursement||-0.36%|
|Net Expense Ratio||0.74%|
The Advisor has contractually agreed to reduce its fees and/or reimburse expenses to keep net expenses (excluding amounts payable pursuant to any plan adopted in accordance with Rule 12b-1, interest expense, taxes, brokerage commissions, acquired fund fees and expenses, other expenditures which are capitalized in accordance with generally accepted accounting principles, and extraordinary expenses) from exceeding 0.75% of the Fund’s average daily net assets for at least one year from the date of the Prospectus.
|Ex-Date||Record Date||Pay Date||Cash Div||ST Cap Gain||LT Cap Gain||Return of Capital||Total Distribution (per share)||YOLO|